TrialClinical cancer research : an official journal of the American Association for Cancer Research2009

Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies.

David S Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.